Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $7.8250 (-3.4%) ($7.8250 - $7.8250) on Tue. Mar. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 42.31% (three month average) | RSI | 43 | Latest Price | $7.8250(-3.4%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -6.8% a day on average for past five trading days. | Weekly Trend | EYES declines -18.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) ONLN(22%) KWEB(42%) MCHI(40%) FXI(33%) VXX(30%) | Factors Impacting EYES price | EYES will decline at least -21.155% in a week (0% probabilities). JNK(-93%) TIP(-45%) VCIT(-40%) TLT(-36%) HYG(-31%) | | | | | Relative Volatility | | | | Market Trend Strength | -21.155% (StdDev 42.31%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $10.62 | 5 Day Moving Average | $8.51(-8.05%) | 10 Day Moving Average | $10.79(-27.48%) | 20 Day Moving Average | $10.62(-26.32%) | To recent high | -49.5% | To recent low | 35.1% | Market Cap | $2.499b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |